Novo Nordisk A/S Common Stock (NVO)

Cost of Revenue

kr 63.75B

TTM · Period ending: · DKK

NVO logo

NVO Cost of Revenue

Latest reportedkr 63.75B DKK
NVO TTM Cost of Revenue · DKK (kr 0.00 → kr 63.75B)
High-resolution chart · PNG

NVO cost of revenue history

Trailing twelve months (TTM) · DKK. Each value covers four complete reported quarters.

Novo Nordisk A/S Common Stock Cost of Revenue — Trailing twelve months (TTM) (DKK)
Period endingCost of Revenue (DKK)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.